Tofacitinib impurity 4 is a characterized small-molecule impurity related to the JAK inhibitor tofacitinib. Supplied as a research-grade reference material, it is intended for analytical method development, impurity profiling, and drug substance characterization. Consult the product data sheet and batch certificate of analysis for assay, purity, and handling instructions before use.